Blog

Think Stocks Will Crash in May? Do These 4 Things Now

When will the stock market crash? That's the big question on many investors' minds at a time when stocks are, across the board, pretty overvalued. In fact, if the stock market doesn't tank

TheMotleyFool

0

Vaxart's Vaccine Candidate Is a Pill, Not a Shot. Does It Matter?

If you've ever ordered a piping hot pizza to your door, you already know that convenience is king. It's no secret that people are willing to pay for products that make their lives easier or less

TheMotleyFool

0

Peloton Tarnishes Its Red-Hot Brand With Safety Missteps

Back in April, the U.S. Consumer Product Safety Commission issued an urgent warning related to Peloton's (NASDAQ: PTON) Tread+ treadmill. The CPSC was aware of 39 incidents of injuries caused by the

TheMotleyFool

0

The Worst Mistake VEREIT Investors Can Make Right Now

VEREIT (NYSE: VER) had a sordid past, but it was finally moving past all of that. And then Realty Income (NYSE: O) came along and made it an all-stock offer it couldn't refuse. Now VEREIT investors

TheMotleyFool

0

Is It Too Late to Buy Johnson & Johnson Stock?

Blue-chip pharmaceutical company Johnson & Johnson (NYSE: Johnson & Johnson) has seen its share of successes over the past 12 months. From developing a COVID-19 vaccine to bolstering a pipeline of

TheMotleyFool

0

3 Growing Stocks That Recently Raised Their Guidance for 2021

With vaccination rates continuing to climb across the country, the end of the pandemic seems to be in sight. And according a recent IPSOS poll, roughly two-thirds of Americans are optimistic that

TheMotleyFool

0

Why Does Cathie Wood Like This Healthcare Stock So Much?

ARK Invest founder and CEO Cathie Wood is a fan of companies that hold the potential to be disruptive. In this Motley Fool Live video recorded on April 21, 2021, Motley Fool contributors Keith

TheMotleyFool

0

Why Sarepta's Q1 Results Won't Spark a Rebound for the Beaten-Down Biotech

Sarepta Therapeutics (NASDAQ: SRPT) has experienced a disastrous year so far, with its shares losing more than half their value. But Wall Street analysts still think that the biotech can turn things

TheMotleyFool

0

Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move

Last year, so-called stay-at-home stocks took off even as the market dropped due to the COVID-19 pandemic. But many of these same companies have struggled since the beginning of this year. Case in

TheMotleyFool

0

Forget Dogecoin: These Stocks Are Infinitely Smarter Buys

For more than a century, the stock market has been the undisputed greatest wealth creator on the planet. Even though certain assets or commodities, such as gold and housing, have had short periods

TheMotleyFool

0

Why Investors Didn't Like 10x Genomics' Q1 Results

10x Genomics (NASDAQ: TXG) has been sizzling hot for much of 2021 so far. It hasn't hurt that Cathie Wood has been busy scooping up shares of the genomics company for her ARK Innovation ETF.

TheMotleyFool

0

2 Stocks to Invest Your Stimulus Check In

On March 11, President Biden signed the American Rescue Plan into law, making tens of millions of Americans eligible for the COVID-19 pandemic's third round of economic stimulus payments. Over 100

TheMotleyFool

0

3 Popular Robinhood Penny Stocks Worth Watching

You get what you pay for. That old adage is true with cars, houses, and any other thing you might buy -- including stocks. When something is cheap, there's usually a good reason why.

Of course, a

TheMotleyFool

0

Vaxart Has 3 Advantages Over Pfizer and Moderna

Things were looking gloomy for Vaxart (NASDAQ: VXRT) a few months ago. The clinical-stage biotech company reported that its COVID-19 vaccine candidate didn't produce neutralizing antibodies in a

TheMotleyFool

0

This Warren Buffett Stock Could Be as Risky as Dogecoin

Warren Buffett didn't take the bait when asked about Bitcoin at the Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) annual shareholder meeting on Saturday. His longtime business partner, Charlie

TheMotleyFool

0

5 Brand-Name Stocks With 27% to 50% Upside, According to Wall Street

For more than a year, Wall Street has been waving a gigantic green flag for the bulls. After dipping below 2,200 on an intraday basis in March 2020, the benchmark S&P 500 closed above 4,200 for the

TheMotleyFool

0

These Top 2 Healthcare Companies Are in a Race to Riches

For patients who go through the rigors of daily insulin shots to treat diabetes, the costs and logistics of adhering to a scheduled plan are a lot to keep up with. When not treated properly, low

TheMotleyFool

0

Claiming Social Security at 65? You May Need to Rethink That

Claiming Social Security at 65 may sound like a good plan.

After all, when Franklin D. Roosevelt created the benefits program in 1935, 65 was set as the "standard" retirement age. Any retiree who

TheMotleyFool

0

3 Things I've Done Right as an Investor

I'm not the type of person who likes to toot her own horn, and I've certainly made my share of investing mistakes through the years. When stocks tanked last March, for example, I tried to buy

TheMotleyFool

0

Why Peloton and Zillow Plunged Despite the Dow's Record Close

The stock market had another topsy-turvy day on Wednesday, with major market benchmarks getting pushed and pulled in both directions at various points. Investors remain concerned about the potential

TheMotleyFool

0